Public-registry trials using evolocumab that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH | LIB Therapeutics LLC | Homozygous Familial Hypercholesterolemia | PHASE3 | 12 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
